These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35235428)

  • 1. Long noncoding RNAs in induced pluripotent stem cells and their differentiation.
    Ilieva M; Uchida S
    Am J Physiol Cell Physiol; 2022 Apr; 322(4):C769-C774. PubMed ID: 35235428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming.
    Du Z; Jia L; Wang Y; Wang C; Wen X; Chen J; Zhu Y; Yu D; Zhou L; Chen N; Zhang S; Celik I; Ay F; Gao S; Zhang S; Li W; Hoffman AR; Cui J; Hu JF
    Sci Data; 2018 Nov; 5():180255. PubMed ID: 30457566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNAs sustain high expression levels of exogenous octamer-binding protein 4 by sponging regulatory microRNAs during cellular reprogramming.
    Zhang X; Zhang J; Zheng K; Zhang H; Pei X; Yin Z; Wen D; Kong Q
    J Biol Chem; 2019 Nov; 294(47):17863-17874. PubMed ID: 31624145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNAs in cell-fate programming and reprogramming.
    Flynn RA; Chang HY
    Cell Stem Cell; 2014 Jun; 14(6):752-61. PubMed ID: 24905165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.
    Sommer CA; Christodoulou C; Gianotti-Sommer A; Shen SS; Sailaja BS; Hezroni H; Spira A; Meshorer E; Kotton DN; Mostoslavsky G
    PLoS One; 2012; 7(12):e51711. PubMed ID: 23272148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large noncoding RNAs are promising regulators in embryonic stem cells.
    Li YP; Wang Y
    J Genet Genomics; 2015 Mar; 42(3):99-105. PubMed ID: 25819086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-modified RNA-Based Reprogramming of Human Dermal Fibroblasts into Induced Pluripotent Stem Cells.
    Belviso I; Di Meglio F; Romano V; Montagnani S; Castaldo C
    Methods Mol Biol; 2022; 2454():675-684. PubMed ID: 33730354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming.
    Kim DH; Marinov GK; Pepke S; Singer ZS; He P; Williams B; Schroth GP; Elowitz MB; Wold BJ
    Cell Stem Cell; 2015 Jan; 16(1):88-101. PubMed ID: 25575081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.
    Cerneckis J; Cai H; Shi Y
    Signal Transduct Target Ther; 2024 Apr; 9(1):112. PubMed ID: 38670977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling mitochondria-polyribosome lncRNAs associated with pluripotency.
    Zhou L; Li H; Sun T; Wen X; Niu C; Li M; Li W; Esteban MA; Hoffman AR; Hu JF; Cui J
    Sci Data; 2023 Nov; 10(1):755. PubMed ID: 37919270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental approaches for the generation of induced pluripotent stem cells.
    Sommer CA; Mostoslavsky G
    Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights and applications of direct neuronal reprogramming.
    Schaukowitch K; Janas JA; Wernig M
    Curr Opin Genet Dev; 2023 Dec; 83():102128. PubMed ID: 37862835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.
    Ohnuki M; Tanabe K; Sutou K; Teramoto I; Sawamura Y; Narita M; Nakamura M; Tokunaga Y; Nakamura M; Watanabe A; Yamanaka S; Takahashi K
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12426-31. PubMed ID: 25097266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Noncoding RNA-mRNA Regulomics Signature in Reprogramming and Pluripotency in iPSCs.
    Salloum-Asfar S; Abdulla SA; Taha RZ; Thompson IR; Emara MM
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
    Ying SY; Fang W; Lin SL
    Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.